AcelRx Pharmaceuticals, Inc. Price Today
AcelRx Pharmaceuticals, Inc.
ACRX
Healthcare
$14.58M
💰
Market Cap
0
💸
Price to Earnings
$-2.8
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
0 |
Strong Buy |
0 |
Hold |
0 |
Sell |
0 |
Strong Sell |
0 |
ACRX Price Forecast Target
0.9 👉 5.0 +481%
ACRX EPS Forecast
-2.8 👉 -0.8 +-72%
Financials
Profit Margin
0 %
Revenue Growth
-76.9 %
Dividend
$ 0
Held Percent
2.6% - Insiders
38.9% - Institutions
58.5% - Public
Major Fund Holders
-
💰 $
-
💰 $
-
💰 $
-
💰 $
-
💰 $
Stock Ideas
David Shaw Portfolio
David Shaw is a renowned computer scientist, technological pioneer, and founder of D.E. Shaw Group, one of the earliest quantitative hedge funds. Shaw pioneered the use of algorithmic and computational modeling in institutional investing. While litt…
Stephen Mandel Portfolio
Stephen Mandel is the founder and portfolio manager of Lone Pine Capital, one of the largest and most successful hedge funds. Employing rigorous fundamental analysis, Mandel searches globally for qualitatively excellent growth companies trading at r…
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
Elon Musk Portfolio
Enter the visionary world of Elon Musk, a name that needs no introduction in the realms of innovation, entrepreneurship, and technology. With a trailblazing spirit and an unyielding drive, Musk has become a household name, propelling himself to extr…📮FAQ
Some Frequently Asked Questions.
The AcelRx Pharmaceuticals, Inc. industry is Drug Manufacturers - Specialty & Generic
The AcelRx Pharmaceuticals, Inc. sector is Healthcare
The AcelRx Pharmaceuticals, Inc. forecasted predicted Price to Earnings PE ratio is -1.1
The AcelRx Pharmaceuticals, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of AcelRx Pharmaceuticals, Inc. is $14.58M
There are total of 12029161 float shares with 38.9% held by Institutions and 2.6% held by insiders
The MAcelRx Pharmaceuticals, Inc. forecasted Earnings per Share EPS is $-0.8
The AcelRx Pharmaceuticals, Inc. Earnings per Share EPS is -2.8
The AcelRx Pharmaceuticals, Inc. company has $-3341000 gross profits with 0 profit margins
The AcelRx Pharmaceuticals, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The AcelRx Pharmaceuticals, Inc. Revenue is $370000 with -0.769 revenue growth
The price target for AcelRx Pharmaceuticals, Inc. stock is $5.0 for the high target and $4.2 for the low target
The consensus analyst recommendations for AcelRx Pharmaceuticals, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for AcelRx Pharmaceuticals, Inc. is Buy, with the following breakdown:
- Buy: 0
- Strong Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
The Beta of AcelRx Pharmaceuticals, Inc. is 0.5
The dividend of AcelRx Pharmaceuticals, Inc. is $0
The dividend yield of AcelRx Pharmaceuticals, Inc. is 0%
The biggest institutional and mutual fund holders of AcelRx Pharmaceuticals, Inc. stock are
The AcelRx Pharmaceuticals, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0